Gene · 338413
Papers2,372
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,372
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia. | Int J Mol Sci | 2022 | 36613920 | PubTator, text mining | PubMed |
| [Anti-tumor effect of Huaier extract supernatant on human gastric cancer HGC-27 and MGC-803 cells]. | Zhongguo Zhong Yao Za Zhi | 2022 | 36604892 | PubTator, text mining | PubMed |
| Targeted protein degradation by Trim-Away using cell resealing coupled with microscopic image-based quantitative analysis. | Front Cell Dev Biol | 2022 | 36601537 | PubTator, text mining | PubMed |
| A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens. | Sci Rep | 2022 | 36572710 | PubTator, text mining | PubMed |
| Molecular dissection of Janus kinases as drug targets for inflammatory diseases. | Front Immunol | 2022 | 36569926 | PubTator, text mining | PubMed |
| Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC). | Biomedicines | 2022 | 36552000 | PubTator, text mining | PubMed |
| Axonal Regeneration: Underlying Molecular Mechanisms and Potential Therapeutic Targets. | Biomedicines | 2022 | 36551942 | PubTator, text mining | PubMed |
| Chemical Constituents of the Deep-Sea-Derived Penicillium citreonigrum MCCC 3A00169 and Their Antiproliferative Effects. | Mar Drugs | 2022 | 36547883 | PubTator, text mining | PubMed |
| Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (LAM). | Cell Death Dis | 2022 | 36543771 | PubTator, text mining | PubMed |
| High tumor burden in non-small-cell lung cancer: A review of the literature. | J Clin Transl Res | 2022 | 36518549 | PubTator, text mining | PubMed |
| Preventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics. | Int J Mol Sci | 2022 | 36498937 | PubTator, text mining | PubMed |
| Delivery of Active AKT1 to Human Cells. | Cells | 2022 | 36497091 | PubTator, text mining | PubMed |
| Mechanistic target of rapamycin complex 1 orchestrates the interplay between hepatocytes and Kupffer cells to determine the outcome of immune-mediated hepatitis. | Cell Death Dis | 2022 | 36494334 | PubTator, text mining | PubMed |
| Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study. | Mol Biomed | 2022 | 36484892 | PubTator, text mining | PubMed |
| WIN Symposium 2022 - Abstract Poster Presentations. | J Immunother Precis Oncol | 2022 | 36483583 | PubTator, text mining | PubMed |
| Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10. | Front Genet | 2022 | 36482893 | PubTator, text mining | PubMed |
| Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. | Nat Commun | 2022 | 36477656 | PubTator, text mining | PubMed |
| Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells. | BMC Cancer | 2022 | 36460969 | PubTator, text mining | PubMed |
| Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2. | Theranostics | 2022 | 36438491 | PubTator, text mining | PubMed |
| Fatigue and Recovery of Muscles for Pulling Tasks. | Int J Environ Res Public Health | 2022 | 36429882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338413/papers?page=16